Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

BACKGROUND AND PURPOSE: Pancreatic cancer is a highly aggressive malignancy, and improvement in systemic therapy is necessary to treat this frequently encountered metastatic disease. The current targeted agents used in combination with gemcitabine improved objective response rates, but with little o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Iwanski, Gabriela B, Lee, Dhong H, En-Gal, Shlomit, Doan, Ngan B, Castor, Brandon, Vogt, Marco, Toh, Melvin, Bokemeyer, Carsten, Said, Jonathan W, Thoennissen, Nils H, Koeffler, H Phillip
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2010
Fag:
Research Papers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936004/
https://ncbi.nlm.nih.gov/pubmed/20590594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2010.00741.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker